Showing results (251-260 of 366) with videos related to
Sort By:
Pageof 37
Analytical Chemistry|January 1, 1997
Genetically engineered bacteria: electrochemical sensing systems for antimonite and arseniteD L Scott, S Ramanathan, W Shi, et al.British Journal of Rheumatology|November 1, 1983
Partial finger loss: an indicator of severe connective tissue disease with overlap featuresG R Struthers, D L Scott, D G Scott, et al.Clinical Rheumatology|March 1, 1985
Joint sepsis as a complication of sero-negative arthritisC S Barker, D P Symmons, D L Scott, et al.Zeitschrift Fur Rheumatologie|September 1, 1975
[Clinical study on a new acetylsalicylic acid/paracetamol preparation with gastric acid resistant coating (Safapryn), and on two various phenylbutazone dosages in patients with primary chronic polyarthritis as based on a new evaluation method]P M Brooks, J J Walker, P Lee, et al.Annals of the Rheumatic Diseases|June 12, 1999
Association of polymorphism in glutathione S-transferase loci with susceptibility and outcome in rheumatoid arthritis: comparison with the shared epitopeD L Mattey, A B Hassell, M Plant, et al.British Journal of Rheumatology|October 1, 1995
Are slow-acting anti-rheumatic drugs monitored too often? An audit of current clinical practiceM Comer, D L Scott, D V Doyle, et al.British Journal of Rheumatology|July 1, 1993
The long-term use of D-penicillamine for treating rheumatoid arthritis: is continuous therapy necessary?D V Doyle, D Perrett, O J Foster, et al.Annals of the Rheumatic Diseases|April 1, 1984
Cancer morbidity in rheumatoid arthritisP Prior, D P Symmons, C F Hawkins, et al.Annals of the Rheumatic Diseases|March 1, 1990
Can we develop simple response criteria for slow acting antirheumatic drugs?D L Scott, J E Dacre, A Greenwood, et al.Journal of Chronic Diseases|January 1, 1986
Factors influencing mortality in rheumatoid arthritisD P Symmons, P Prior, D L Scott, et al.Pageof 37